Interim Subgroup Analysis For Response By Pd-L1 Status Of Classical-Lung, A Phase Ib/Ii Study Of Pepinemab (Vx15/2503) In Combination With Avelumab In Advanced Nsclc.
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
3011Background: Antibody blockade of semaphorin 4D (SEMA4D, CD100) promotes tumoral dendritic cell and CD8+ T cell infiltration and reduces function and recruitment of immunosuppressive myeloid cel...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要